nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—CYP3A7-CYP3A51P—Salmeterol—asthma	0.0396	0.0687	CbGbCtD
Sirolimus—CYP3A7—Salmeterol—asthma	0.0396	0.0687	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Fluticasone Propionate—asthma	0.0337	0.0584	CbGbCtD
Sirolimus—CYP3A7—Fluticasone Propionate—asthma	0.0337	0.0584	CbGbCtD
Sirolimus—CYP3A5—Beclomethasone—asthma	0.0297	0.0515	CbGbCtD
Sirolimus—CYP3A5—Salmeterol—asthma	0.0297	0.0515	CbGbCtD
Sirolimus—ABCB1—Fluticasone furoate—asthma	0.0255	0.0443	CbGbCtD
Sirolimus—CYP3A5—Fluticasone Propionate—asthma	0.0253	0.0438	CbGbCtD
Sirolimus—ABCB1—Indacaterol—asthma	0.0208	0.0361	CbGbCtD
Sirolimus—CYP3A4—Fluticasone furoate—asthma	0.0153	0.0265	CbGbCtD
Sirolimus—CYP3A4—Budesonide—asthma	0.0136	0.0236	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Hydrocortisone—asthma	0.0126	0.0219	CbGbCtD
Sirolimus—CYP3A7—Hydrocortisone—asthma	0.0126	0.0219	CbGbCtD
Sirolimus—CYP3A4—Ciclesonide—asthma	0.0125	0.0216	CbGbCtD
Sirolimus—CYP3A4—Indacaterol—asthma	0.0125	0.0216	CbGbCtD
Sirolimus—CYP3A4—Salmeterol—asthma	0.0116	0.0201	CbGbCtD
Sirolimus—CYP3A4—Salbutamol—asthma	0.0116	0.0201	CbGbCtD
Sirolimus—CYP3A4—Flunisolide—asthma	0.0116	0.0201	CbGbCtD
Sirolimus—ABCB1—Loratadine—asthma	0.0111	0.0193	CbGbCtD
Sirolimus—CYP3A4—Zileuton—asthma	0.0103	0.0179	CbGbCtD
Sirolimus—CYP3A4—Ipratropium bromide—asthma	0.0103	0.0179	CbGbCtD
Sirolimus—ABCB1—Methylprednisolone—asthma	0.0102	0.0176	CbGbCtD
Sirolimus—CYP3A4—Fluticasone Propionate—asthma	0.00985	0.0171	CbGbCtD
Sirolimus—CYP3A5—Hydrocortisone—asthma	0.00949	0.0165	CbGbCtD
Sirolimus—CYP3A4—Zafirlukast—asthma	0.00909	0.0158	CbGbCtD
Sirolimus—CYP3A7—Dexamethasone—asthma	0.00787	0.0136	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dexamethasone—asthma	0.00787	0.0136	CbGbCtD
Sirolimus—CYP3A4—Tiotropium—asthma	0.00782	0.0136	CbGbCtD
Sirolimus—CYP3A4—Aminophylline—asthma	0.00746	0.0129	CbGbCtD
Sirolimus—CYP3A4—Theophylline—asthma	0.00702	0.0122	CbGbCtD
Sirolimus—CYP3A4—Montelukast—asthma	0.00665	0.0115	CbGbCtD
Sirolimus—CYP3A4—Loratadine—asthma	0.00665	0.0115	CbGbCtD
Sirolimus—ABCB1—Betamethasone—asthma	0.0066	0.0115	CbGbCtD
Sirolimus—ABCB1—Prednisolone—asthma	0.00651	0.0113	CbGbCtD
Sirolimus—ABCB1—Hydrocortisone—asthma	0.00617	0.0107	CbGbCtD
Sirolimus—ABCB1—Prednisone—asthma	0.00615	0.0107	CbGbCtD
Sirolimus—CYP3A4—Methylprednisolone—asthma	0.00608	0.0106	CbGbCtD
Sirolimus—CYP3A5—Dexamethasone—asthma	0.0059	0.0102	CbGbCtD
Sirolimus—EIF4E—respiratory system—asthma	0.00486	0.101	CbGeAlD
Sirolimus—CYP3A4—Triamcinolone—asthma	0.00461	0.008	CbGbCtD
Sirolimus—CYP3A4—Betamethasone—asthma	0.00396	0.00686	CbGbCtD
Sirolimus—CYP3A4—Prednisolone—asthma	0.0039	0.00677	CbGbCtD
Sirolimus—ABCB1—Dexamethasone—asthma	0.00384	0.00666	CbGbCtD
Sirolimus—EIF4E—cardiovascular system—asthma	0.00373	0.0777	CbGeAlD
Sirolimus—CYP3A4—Hydrocortisone—asthma	0.0037	0.00642	CbGbCtD
Sirolimus—CYP3A4—Prednisone—asthma	0.00369	0.00639	CbGbCtD
Sirolimus—EIF4E—lung—asthma	0.00258	0.0539	CbGeAlD
Sirolimus—FGF2—bronchus—asthma	0.00244	0.0509	CbGeAlD
Sirolimus—FGF2—smooth muscle tissue—asthma	0.00239	0.0498	CbGeAlD
Sirolimus—CYP3A4—Dexamethasone—asthma	0.0023	0.00399	CbGbCtD
Sirolimus—FGF2—trachea—asthma	0.00219	0.0457	CbGeAlD
Sirolimus—MTOR—respiratory system—asthma	0.00188	0.0392	CbGeAlD
Sirolimus—FGF2—adrenal gland—asthma	0.0018	0.0375	CbGeAlD
Sirolimus—FKBP1A—respiratory system—asthma	0.00169	0.0353	CbGeAlD
Sirolimus—FGF2—lung—asthma	0.00157	0.0328	CbGeAlD
Sirolimus—MTOR—epithelium—asthma	0.00157	0.0328	CbGeAlD
Sirolimus—MTOR—smooth muscle tissue—asthma	0.00152	0.0316	CbGeAlD
Sirolimus—MTOR—cardiovascular system—asthma	0.00144	0.0301	CbGeAlD
Sirolimus—FKBP1A—adrenal cortex—asthma	0.00142	0.0296	CbGeAlD
Sirolimus—FKBP1A—epithelium—asthma	0.00141	0.0295	CbGeAlD
Sirolimus—FKBP1A—bronchus—asthma	0.00139	0.029	CbGeAlD
Sirolimus—FKBP1A—smooth muscle tissue—asthma	0.00136	0.0284	CbGeAlD
Sirolimus—FKBP1A—cardiovascular system—asthma	0.0013	0.027	CbGeAlD
Sirolimus—FKBP1A—trachea—asthma	0.00125	0.0261	CbGeAlD
Sirolimus—SLC47A1—adrenal cortex—asthma	0.00122	0.0255	CbGeAlD
Sirolimus—MTOR—adrenal gland—asthma	0.00114	0.0238	CbGeAlD
Sirolimus—FKBP1A—adrenal gland—asthma	0.00103	0.0214	CbGeAlD
Sirolimus—MTOR—lung—asthma	0.000999	0.0208	CbGeAlD
Sirolimus—FKBP1A—lung—asthma	0.000899	0.0187	CbGeAlD
Sirolimus—SLC47A1—adrenal gland—asthma	0.000881	0.0184	CbGeAlD
Sirolimus—SLC47A1—lung—asthma	0.000772	0.0161	CbGeAlD
Sirolimus—CYP3A5—respiratory system—asthma	0.000737	0.0154	CbGeAlD
Sirolimus—ABCB1—respiratory system—asthma	0.000392	0.00816	CbGeAlD
Sirolimus—CYP3A5—lung—asthma	0.000391	0.00816	CbGeAlD
Sirolimus—ABCB1—adrenal cortex—asthma	0.000329	0.00685	CbGeAlD
Sirolimus—ABCB1—epithelium—asthma	0.000327	0.00682	CbGeAlD
Sirolimus—ABCB1—cardiovascular system—asthma	0.0003	0.00625	CbGeAlD
Sirolimus—ABCB1—trachea—asthma	0.000289	0.00603	CbGeAlD
Sirolimus—ABCB1—adrenal gland—asthma	0.000237	0.00495	CbGeAlD
Sirolimus—ABCB1—lung—asthma	0.000208	0.00434	CbGeAlD
Sirolimus—Ill-defined disorder—Triamcinolone—asthma	3.83e-05	0.000153	CcSEcCtD
Sirolimus—Ill-defined disorder—Methylprednisolone—asthma	3.82e-05	0.000152	CcSEcCtD
Sirolimus—Nausea—Salbutamol—asthma	3.79e-05	0.000151	CcSEcCtD
Sirolimus—Hypertension—Hydrocortisone—asthma	3.79e-05	0.000151	CcSEcCtD
Sirolimus—Discomfort—Prednisolone—asthma	3.78e-05	0.000151	CcSEcCtD
Sirolimus—Angioedema—Triamcinolone—asthma	3.77e-05	0.00015	CcSEcCtD
Sirolimus—Haemoglobin—Prednisone—asthma	3.77e-05	0.00015	CcSEcCtD
Sirolimus—Angioedema—Methylprednisolone—asthma	3.76e-05	0.00015	CcSEcCtD
Sirolimus—Haemorrhage—Prednisone—asthma	3.75e-05	0.000149	CcSEcCtD
Sirolimus—Myalgia—Hydrocortisone—asthma	3.73e-05	0.000149	CcSEcCtD
Sirolimus—Hallucination—Prednisone—asthma	3.73e-05	0.000149	CcSEcCtD
Sirolimus—Malaise—Triamcinolone—asthma	3.72e-05	0.000148	CcSEcCtD
Sirolimus—Anxiety—Hydrocortisone—asthma	3.72e-05	0.000148	CcSEcCtD
Sirolimus—Malaise—Methylprednisolone—asthma	3.71e-05	0.000148	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	3.71e-05	0.000148	CcSEcCtD
Sirolimus—Syncope—Triamcinolone—asthma	3.7e-05	0.000148	CcSEcCtD
Sirolimus—Syncope—Methylprednisolone—asthma	3.69e-05	0.000147	CcSEcCtD
Sirolimus—Discomfort—Hydrocortisone—asthma	3.69e-05	0.000147	CcSEcCtD
Sirolimus—Connective tissue disorder—Prednisone—asthma	3.68e-05	0.000147	CcSEcCtD
Sirolimus—Nausea—Budesonide—asthma	3.68e-05	0.000147	CcSEcCtD
Sirolimus—Oedema—Prednisolone—asthma	3.66e-05	0.000146	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisolone—asthma	3.66e-05	0.000146	CcSEcCtD
Sirolimus—Loss of consciousness—Triamcinolone—asthma	3.63e-05	0.000145	CcSEcCtD
Sirolimus—Loss of consciousness—Methylprednisolone—asthma	3.62e-05	0.000144	CcSEcCtD
Sirolimus—Shock—Prednisolone—asthma	3.6e-05	0.000144	CcSEcCtD
Sirolimus—Cough—Triamcinolone—asthma	3.6e-05	0.000144	CcSEcCtD
Sirolimus—Oedema—Hydrocortisone—asthma	3.58e-05	0.000143	CcSEcCtD
Sirolimus—Anaphylactic shock—Hydrocortisone—asthma	3.58e-05	0.000143	CcSEcCtD
Sirolimus—Tachycardia—Prednisolone—asthma	3.58e-05	0.000143	CcSEcCtD
Sirolimus—Hypertension—Triamcinolone—asthma	3.56e-05	0.000142	CcSEcCtD
Sirolimus—Hypertension—Methylprednisolone—asthma	3.56e-05	0.000142	CcSEcCtD
Sirolimus—Infection—Hydrocortisone—asthma	3.55e-05	0.000142	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisolone—asthma	3.54e-05	0.000141	CcSEcCtD
Sirolimus—Shock—Hydrocortisone—asthma	3.52e-05	0.00014	CcSEcCtD
Sirolimus—Myalgia—Triamcinolone—asthma	3.51e-05	0.00014	CcSEcCtD
Sirolimus—Nervous system disorder—Hydrocortisone—asthma	3.51e-05	0.00014	CcSEcCtD
Sirolimus—Myalgia—Methylprednisolone—asthma	3.51e-05	0.00014	CcSEcCtD
Sirolimus—Arthralgia—Methylprednisolone—asthma	3.51e-05	0.00014	CcSEcCtD
Sirolimus—Anxiety—Methylprednisolone—asthma	3.49e-05	0.000139	CcSEcCtD
Sirolimus—Tachycardia—Hydrocortisone—asthma	3.49e-05	0.000139	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	3.48e-05	0.000139	CcSEcCtD
Sirolimus—Skin disorder—Hydrocortisone—asthma	3.48e-05	0.000139	CcSEcCtD
Sirolimus—Ill-defined disorder—Betamethasone—asthma	3.48e-05	0.000139	CcSEcCtD
Sirolimus—Ill-defined disorder—Dexamethasone—asthma	3.48e-05	0.000139	CcSEcCtD
Sirolimus—Discomfort—Triamcinolone—asthma	3.47e-05	0.000138	CcSEcCtD
Sirolimus—Discomfort—Methylprednisolone—asthma	3.46e-05	0.000138	CcSEcCtD
Sirolimus—Hyperhidrosis—Hydrocortisone—asthma	3.46e-05	0.000138	CcSEcCtD
Sirolimus—Angioedema—Betamethasone—asthma	3.42e-05	0.000136	CcSEcCtD
Sirolimus—Angioedema—Dexamethasone—asthma	3.42e-05	0.000136	CcSEcCtD
Sirolimus—Anorexia—Hydrocortisone—asthma	3.41e-05	0.000136	CcSEcCtD
Sirolimus—Angiopathy—Prednisone—asthma	3.4e-05	0.000136	CcSEcCtD
Sirolimus—Confusional state—Methylprednisolone—asthma	3.39e-05	0.000135	CcSEcCtD
Sirolimus—Immune system disorder—Prednisone—asthma	3.38e-05	0.000135	CcSEcCtD
Sirolimus—Malaise—Dexamethasone—asthma	3.38e-05	0.000135	CcSEcCtD
Sirolimus—Malaise—Betamethasone—asthma	3.38e-05	0.000135	CcSEcCtD
Sirolimus—Oedema—Triamcinolone—asthma	3.37e-05	0.000134	CcSEcCtD
Sirolimus—Anaphylactic shock—Triamcinolone—asthma	3.37e-05	0.000134	CcSEcCtD
Sirolimus—Anaphylactic shock—Methylprednisolone—asthma	3.36e-05	0.000134	CcSEcCtD
Sirolimus—Syncope—Betamethasone—asthma	3.36e-05	0.000134	CcSEcCtD
Sirolimus—Syncope—Dexamethasone—asthma	3.36e-05	0.000134	CcSEcCtD
Sirolimus—Infection—Triamcinolone—asthma	3.35e-05	0.000133	CcSEcCtD
Sirolimus—Hypotension—Hydrocortisone—asthma	3.34e-05	0.000133	CcSEcCtD
Sirolimus—Infection—Methylprednisolone—asthma	3.34e-05	0.000133	CcSEcCtD
Sirolimus—Shock—Triamcinolone—asthma	3.31e-05	0.000132	CcSEcCtD
Sirolimus—Insomnia—Prednisolone—asthma	3.31e-05	0.000132	CcSEcCtD
Sirolimus—Shock—Methylprednisolone—asthma	3.31e-05	0.000132	CcSEcCtD
Sirolimus—Nervous system disorder—Methylprednisolone—asthma	3.3e-05	0.000131	CcSEcCtD
Sirolimus—Loss of consciousness—Dexamethasone—asthma	3.29e-05	0.000131	CcSEcCtD
Sirolimus—Loss of consciousness—Betamethasone—asthma	3.29e-05	0.000131	CcSEcCtD
Sirolimus—Paraesthesia—Prednisolone—asthma	3.29e-05	0.000131	CcSEcCtD
Sirolimus—Tachycardia—Triamcinolone—asthma	3.29e-05	0.000131	CcSEcCtD
Sirolimus—Tachycardia—Methylprednisolone—asthma	3.28e-05	0.000131	CcSEcCtD
Sirolimus—Skin disorder—Methylprednisolone—asthma	3.27e-05	0.00013	CcSEcCtD
Sirolimus—Malnutrition—Prednisone—asthma	3.26e-05	0.00013	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Hydrocortisone—asthma	3.26e-05	0.00013	CcSEcCtD
Sirolimus—Hyperhidrosis—Triamcinolone—asthma	3.26e-05	0.00013	CcSEcCtD
Sirolimus—Hyperhidrosis—Methylprednisolone—asthma	3.25e-05	0.00013	CcSEcCtD
Sirolimus—Insomnia—Hydrocortisone—asthma	3.24e-05	0.000129	CcSEcCtD
Sirolimus—Hypertension—Betamethasone—asthma	3.23e-05	0.000129	CcSEcCtD
Sirolimus—Hypertension—Dexamethasone—asthma	3.23e-05	0.000129	CcSEcCtD
Sirolimus—Paraesthesia—Hydrocortisone—asthma	3.21e-05	0.000128	CcSEcCtD
Sirolimus—Myalgia—Dexamethasone—asthma	3.19e-05	0.000127	CcSEcCtD
Sirolimus—Myalgia—Betamethasone—asthma	3.19e-05	0.000127	CcSEcCtD
Sirolimus—Anxiety—Betamethasone—asthma	3.18e-05	0.000127	CcSEcCtD
Sirolimus—Anxiety—Dexamethasone—asthma	3.18e-05	0.000127	CcSEcCtD
Sirolimus—Discomfort—Betamethasone—asthma	3.15e-05	0.000126	CcSEcCtD
Sirolimus—Discomfort—Dexamethasone—asthma	3.15e-05	0.000126	CcSEcCtD
Sirolimus—Dyspepsia—Hydrocortisone—asthma	3.15e-05	0.000126	CcSEcCtD
Sirolimus—Hypotension—Methylprednisolone—asthma	3.14e-05	0.000125	CcSEcCtD
Sirolimus—Pain—Prednisolone—asthma	3.13e-05	0.000125	CcSEcCtD
Sirolimus—Decreased appetite—Hydrocortisone—asthma	3.11e-05	0.000124	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Hydrocortisone—asthma	3.09e-05	0.000123	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Triamcinolone—asthma	3.07e-05	0.000122	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methylprednisolone—asthma	3.06e-05	0.000122	CcSEcCtD
Sirolimus—Pain—Hydrocortisone—asthma	3.06e-05	0.000122	CcSEcCtD
Sirolimus—Oedema—Dexamethasone—asthma	3.06e-05	0.000122	CcSEcCtD
Sirolimus—Anaphylactic shock—Dexamethasone—asthma	3.06e-05	0.000122	CcSEcCtD
Sirolimus—Oedema—Betamethasone—asthma	3.06e-05	0.000122	CcSEcCtD
Sirolimus—Anaphylactic shock—Betamethasone—asthma	3.06e-05	0.000122	CcSEcCtD
Sirolimus—Insomnia—Triamcinolone—asthma	3.05e-05	0.000122	CcSEcCtD
Sirolimus—Insomnia—Methylprednisolone—asthma	3.04e-05	0.000121	CcSEcCtD
Sirolimus—Infection—Betamethasone—asthma	3.04e-05	0.000121	CcSEcCtD
Sirolimus—Infection—Dexamethasone—asthma	3.04e-05	0.000121	CcSEcCtD
Sirolimus—Ill-defined disorder—Prednisone—asthma	3.03e-05	0.000121	CcSEcCtD
Sirolimus—Paraesthesia—Triamcinolone—asthma	3.03e-05	0.000121	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisolone—asthma	3.02e-05	0.00012	CcSEcCtD
Sirolimus—Paraesthesia—Methylprednisolone—asthma	3.02e-05	0.00012	CcSEcCtD
Sirolimus—Anaemia—Prednisone—asthma	3.02e-05	0.00012	CcSEcCtD
Sirolimus—Shock—Dexamethasone—asthma	3.01e-05	0.00012	CcSEcCtD
Sirolimus—Shock—Betamethasone—asthma	3.01e-05	0.00012	CcSEcCtD
Sirolimus—Dyspnoea—Triamcinolone—asthma	3e-05	0.00012	CcSEcCtD
Sirolimus—Nervous system disorder—Betamethasone—asthma	3e-05	0.00012	CcSEcCtD
Sirolimus—Nervous system disorder—Dexamethasone—asthma	3e-05	0.00012	CcSEcCtD
Sirolimus—Agitation—Prednisone—asthma	3e-05	0.00012	CcSEcCtD
Sirolimus—Thrombocytopenia—Betamethasone—asthma	2.99e-05	0.000119	CcSEcCtD
Sirolimus—Thrombocytopenia—Dexamethasone—asthma	2.99e-05	0.000119	CcSEcCtD
Sirolimus—Tachycardia—Betamethasone—asthma	2.98e-05	0.000119	CcSEcCtD
Sirolimus—Tachycardia—Dexamethasone—asthma	2.98e-05	0.000119	CcSEcCtD
Sirolimus—Angioedema—Prednisone—asthma	2.98e-05	0.000119	CcSEcCtD
Sirolimus—Dyspepsia—Triamcinolone—asthma	2.97e-05	0.000118	CcSEcCtD
Sirolimus—Dyspepsia—Methylprednisolone—asthma	2.96e-05	0.000118	CcSEcCtD
Sirolimus—Hyperhidrosis—Dexamethasone—asthma	2.96e-05	0.000118	CcSEcCtD
Sirolimus—Hyperhidrosis—Betamethasone—asthma	2.96e-05	0.000118	CcSEcCtD
Sirolimus—Feeling abnormal—Hydrocortisone—asthma	2.95e-05	0.000118	CcSEcCtD
Sirolimus—Malaise—Prednisone—asthma	2.94e-05	0.000117	CcSEcCtD
Sirolimus—Gastrointestinal pain—Hydrocortisone—asthma	2.93e-05	0.000117	CcSEcCtD
Sirolimus—Syncope—Prednisone—asthma	2.93e-05	0.000117	CcSEcCtD
Sirolimus—Anorexia—Betamethasone—asthma	2.91e-05	0.000116	CcSEcCtD
Sirolimus—Anorexia—Dexamethasone—asthma	2.91e-05	0.000116	CcSEcCtD
Sirolimus—Pain—Triamcinolone—asthma	2.88e-05	0.000115	CcSEcCtD
Sirolimus—Loss of consciousness—Prednisone—asthma	2.87e-05	0.000114	CcSEcCtD
Sirolimus—Hypotension—Dexamethasone—asthma	2.86e-05	0.000114	CcSEcCtD
Sirolimus—Hypotension—Betamethasone—asthma	2.86e-05	0.000114	CcSEcCtD
Sirolimus—Body temperature increased—Hydrocortisone—asthma	2.83e-05	0.000113	CcSEcCtD
Sirolimus—Abdominal pain—Hydrocortisone—asthma	2.83e-05	0.000113	CcSEcCtD
Sirolimus—Hypertension—Prednisone—asthma	2.82e-05	0.000112	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Betamethasone—asthma	2.79e-05	0.000111	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Dexamethasone—asthma	2.79e-05	0.000111	CcSEcCtD
Sirolimus—Myalgia—Prednisone—asthma	2.78e-05	0.000111	CcSEcCtD
Sirolimus—Arthralgia—Prednisone—asthma	2.78e-05	0.000111	CcSEcCtD
Sirolimus—Feeling abnormal—Triamcinolone—asthma	2.78e-05	0.000111	CcSEcCtD
Sirolimus—Feeling abnormal—Methylprednisolone—asthma	2.77e-05	0.00011	CcSEcCtD
Sirolimus—Anxiety—Prednisone—asthma	2.77e-05	0.00011	CcSEcCtD
Sirolimus—Insomnia—Dexamethasone—asthma	2.76e-05	0.00011	CcSEcCtD
Sirolimus—Insomnia—Betamethasone—asthma	2.76e-05	0.00011	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.76e-05	0.00011	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methylprednisolone—asthma	2.75e-05	0.00011	CcSEcCtD
Sirolimus—Paraesthesia—Betamethasone—asthma	2.75e-05	0.000109	CcSEcCtD
Sirolimus—Paraesthesia—Dexamethasone—asthma	2.75e-05	0.000109	CcSEcCtD
Sirolimus—Discomfort—Prednisone—asthma	2.74e-05	0.000109	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisolone—asthma	2.7e-05	0.000108	CcSEcCtD
Sirolimus—Dyspepsia—Dexamethasone—asthma	2.69e-05	0.000107	CcSEcCtD
Sirolimus—Dyspepsia—Betamethasone—asthma	2.69e-05	0.000107	CcSEcCtD
Sirolimus—Body temperature increased—Triamcinolone—asthma	2.66e-05	0.000106	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisone—asthma	2.66e-05	0.000106	CcSEcCtD
Sirolimus—Oedema—Prednisone—asthma	2.66e-05	0.000106	CcSEcCtD
Sirolimus—Abdominal pain—Methylprednisolone—asthma	2.66e-05	0.000106	CcSEcCtD
Sirolimus—Decreased appetite—Betamethasone—asthma	2.66e-05	0.000106	CcSEcCtD
Sirolimus—Decreased appetite—Dexamethasone—asthma	2.66e-05	0.000106	CcSEcCtD
Sirolimus—Infection—Prednisone—asthma	2.64e-05	0.000105	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Betamethasone—asthma	2.64e-05	0.000105	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Dexamethasone—asthma	2.64e-05	0.000105	CcSEcCtD
Sirolimus—Hypersensitivity—Hydrocortisone—asthma	2.64e-05	0.000105	CcSEcCtD
Sirolimus—Shock—Prednisone—asthma	2.62e-05	0.000104	CcSEcCtD
Sirolimus—Pain—Dexamethasone—asthma	2.61e-05	0.000104	CcSEcCtD
Sirolimus—Pain—Betamethasone—asthma	2.61e-05	0.000104	CcSEcCtD
Sirolimus—Nervous system disorder—Prednisone—asthma	2.61e-05	0.000104	CcSEcCtD
Sirolimus—Tachycardia—Prednisone—asthma	2.6e-05	0.000104	CcSEcCtD
Sirolimus—Skin disorder—Prednisone—asthma	2.59e-05	0.000103	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisone—asthma	2.57e-05	0.000103	CcSEcCtD
Sirolimus—Asthenia—Hydrocortisone—asthma	2.57e-05	0.000102	CcSEcCtD
Sirolimus—Anorexia—Prednisone—asthma	2.54e-05	0.000101	CcSEcCtD
Sirolimus—Pruritus—Hydrocortisone—asthma	2.53e-05	0.000101	CcSEcCtD
Sirolimus—Feeling abnormal—Betamethasone—asthma	2.52e-05	0.0001	CcSEcCtD
Sirolimus—Feeling abnormal—Dexamethasone—asthma	2.52e-05	0.0001	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dexamethasone—asthma	2.5e-05	9.97e-05	CcSEcCtD
Sirolimus—Gastrointestinal pain—Betamethasone—asthma	2.5e-05	9.97e-05	CcSEcCtD
Sirolimus—Hypersensitivity—Triamcinolone—asthma	2.48e-05	9.9e-05	CcSEcCtD
Sirolimus—Hypersensitivity—Methylprednisolone—asthma	2.48e-05	9.88e-05	CcSEcCtD
Sirolimus—Diarrhoea—Hydrocortisone—asthma	2.45e-05	9.76e-05	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Prednisone—asthma	2.43e-05	9.67e-05	CcSEcCtD
Sirolimus—Dizziness—Prednisolone—asthma	2.42e-05	9.66e-05	CcSEcCtD
Sirolimus—Asthenia—Triamcinolone—asthma	2.42e-05	9.64e-05	CcSEcCtD
Sirolimus—Abdominal pain—Dexamethasone—asthma	2.42e-05	9.64e-05	CcSEcCtD
Sirolimus—Body temperature increased—Betamethasone—asthma	2.42e-05	9.64e-05	CcSEcCtD
Sirolimus—Abdominal pain—Betamethasone—asthma	2.42e-05	9.64e-05	CcSEcCtD
Sirolimus—Body temperature increased—Dexamethasone—asthma	2.42e-05	9.64e-05	CcSEcCtD
Sirolimus—Asthenia—Methylprednisolone—asthma	2.41e-05	9.62e-05	CcSEcCtD
Sirolimus—Insomnia—Prednisone—asthma	2.41e-05	9.6e-05	CcSEcCtD
Sirolimus—Paraesthesia—Prednisone—asthma	2.39e-05	9.53e-05	CcSEcCtD
Sirolimus—Pruritus—Triamcinolone—asthma	2.38e-05	9.5e-05	CcSEcCtD
Sirolimus—Pruritus—Methylprednisolone—asthma	2.38e-05	9.48e-05	CcSEcCtD
Sirolimus—Dizziness—Hydrocortisone—asthma	2.37e-05	9.43e-05	CcSEcCtD
Sirolimus—Dyspepsia—Prednisone—asthma	2.34e-05	9.34e-05	CcSEcCtD
Sirolimus—Decreased appetite—Prednisone—asthma	2.31e-05	9.23e-05	CcSEcCtD
Sirolimus—Rash—Prednisolone—asthma	2.31e-05	9.21e-05	CcSEcCtD
Sirolimus—Dermatitis—Prednisolone—asthma	2.31e-05	9.2e-05	CcSEcCtD
Sirolimus—Diarrhoea—Methylprednisolone—asthma	2.3e-05	9.17e-05	CcSEcCtD
Sirolimus—Headache—Prednisolone—asthma	2.3e-05	9.15e-05	CcSEcCtD
Sirolimus—Constipation—Prednisone—asthma	2.28e-05	9.08e-05	CcSEcCtD
Sirolimus—Vomiting—Hydrocortisone—asthma	2.28e-05	9.07e-05	CcSEcCtD
Sirolimus—Rash—Hydrocortisone—asthma	2.26e-05	9e-05	CcSEcCtD
Sirolimus—Dermatitis—Hydrocortisone—asthma	2.25e-05	8.99e-05	CcSEcCtD
Sirolimus—Headache—Hydrocortisone—asthma	2.24e-05	8.94e-05	CcSEcCtD
Sirolimus—Dizziness—Triamcinolone—asthma	2.23e-05	8.88e-05	CcSEcCtD
Sirolimus—Dizziness—Methylprednisolone—asthma	2.22e-05	8.86e-05	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisone—asthma	2.19e-05	8.75e-05	CcSEcCtD
Sirolimus—Asthenia—Dexamethasone—asthma	2.19e-05	8.75e-05	CcSEcCtD
Sirolimus—Asthenia—Betamethasone—asthma	2.19e-05	8.75e-05	CcSEcCtD
Sirolimus—Gastrointestinal pain—Prednisone—asthma	2.18e-05	8.68e-05	CcSEcCtD
Sirolimus—Nausea—Prednisolone—asthma	2.18e-05	8.68e-05	CcSEcCtD
Sirolimus—Pruritus—Dexamethasone—asthma	2.16e-05	8.62e-05	CcSEcCtD
Sirolimus—Pruritus—Betamethasone—asthma	2.16e-05	8.62e-05	CcSEcCtD
Sirolimus—Vomiting—Triamcinolone—asthma	2.14e-05	8.54e-05	CcSEcCtD
Sirolimus—Vomiting—Methylprednisolone—asthma	2.14e-05	8.52e-05	CcSEcCtD
Sirolimus—Nausea—Hydrocortisone—asthma	2.13e-05	8.47e-05	CcSEcCtD
Sirolimus—Rash—Triamcinolone—asthma	2.12e-05	8.47e-05	CcSEcCtD
Sirolimus—Dermatitis—Triamcinolone—asthma	2.12e-05	8.46e-05	CcSEcCtD
Sirolimus—Rash—Methylprednisolone—asthma	2.12e-05	8.45e-05	CcSEcCtD
Sirolimus—Dermatitis—Methylprednisolone—asthma	2.12e-05	8.44e-05	CcSEcCtD
Sirolimus—Headache—Triamcinolone—asthma	2.11e-05	8.42e-05	CcSEcCtD
Sirolimus—Headache—Methylprednisolone—asthma	2.11e-05	8.4e-05	CcSEcCtD
Sirolimus—Abdominal pain—Prednisone—asthma	2.1e-05	8.39e-05	CcSEcCtD
Sirolimus—Body temperature increased—Prednisone—asthma	2.1e-05	8.39e-05	CcSEcCtD
Sirolimus—Diarrhoea—Betamethasone—asthma	2.09e-05	8.34e-05	CcSEcCtD
Sirolimus—Diarrhoea—Dexamethasone—asthma	2.09e-05	8.34e-05	CcSEcCtD
Sirolimus—Dizziness—Dexamethasone—asthma	2.02e-05	8.06e-05	CcSEcCtD
Sirolimus—Dizziness—Betamethasone—asthma	2.02e-05	8.06e-05	CcSEcCtD
Sirolimus—Nausea—Triamcinolone—asthma	2e-05	7.98e-05	CcSEcCtD
Sirolimus—Nausea—Methylprednisolone—asthma	2e-05	7.96e-05	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisone—asthma	1.96e-05	7.82e-05	CcSEcCtD
Sirolimus—Vomiting—Betamethasone—asthma	1.94e-05	7.75e-05	CcSEcCtD
Sirolimus—Vomiting—Dexamethasone—asthma	1.94e-05	7.75e-05	CcSEcCtD
Sirolimus—Rash—Betamethasone—asthma	1.93e-05	7.69e-05	CcSEcCtD
Sirolimus—Rash—Dexamethasone—asthma	1.93e-05	7.69e-05	CcSEcCtD
Sirolimus—Dermatitis—Dexamethasone—asthma	1.93e-05	7.68e-05	CcSEcCtD
Sirolimus—Dermatitis—Betamethasone—asthma	1.93e-05	7.68e-05	CcSEcCtD
Sirolimus—Headache—Dexamethasone—asthma	1.92e-05	7.64e-05	CcSEcCtD
Sirolimus—Headache—Betamethasone—asthma	1.92e-05	7.64e-05	CcSEcCtD
Sirolimus—Asthenia—Prednisone—asthma	1.91e-05	7.62e-05	CcSEcCtD
Sirolimus—Pruritus—Prednisone—asthma	1.88e-05	7.51e-05	CcSEcCtD
Sirolimus—Diarrhoea—Prednisone—asthma	1.82e-05	7.26e-05	CcSEcCtD
Sirolimus—Nausea—Dexamethasone—asthma	1.82e-05	7.24e-05	CcSEcCtD
Sirolimus—Nausea—Betamethasone—asthma	1.82e-05	7.24e-05	CcSEcCtD
Sirolimus—Dizziness—Prednisone—asthma	1.76e-05	7.02e-05	CcSEcCtD
Sirolimus—Vomiting—Prednisone—asthma	1.69e-05	6.75e-05	CcSEcCtD
Sirolimus—Rash—Prednisone—asthma	1.68e-05	6.69e-05	CcSEcCtD
Sirolimus—Dermatitis—Prednisone—asthma	1.68e-05	6.69e-05	CcSEcCtD
Sirolimus—Headache—Prednisone—asthma	1.67e-05	6.65e-05	CcSEcCtD
Sirolimus—Nausea—Prednisone—asthma	1.58e-05	6.31e-05	CcSEcCtD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—asthma	1.18e-05	9.46e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—BDKRB2—asthma	1.18e-05	9.42e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ARG2—asthma	1.18e-05	9.41e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PPP2CA—asthma	1.17e-05	9.38e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ADCY2—asthma	1.17e-05	9.37e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—POMC—asthma	1.17e-05	9.36e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—PTEN—asthma	1.16e-05	9.32e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.16e-05	9.29e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—asthma	1.16e-05	9.28e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SMAD3—asthma	1.16e-05	9.26e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CCR5—asthma	1.15e-05	9.22e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADCY2—asthma	1.14e-05	9.11e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL3—asthma	1.13e-05	9.08e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL2—asthma	1.13e-05	9.04e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—POMC—asthma	1.12e-05	8.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—PTEN—asthma	1.12e-05	8.95e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTEN—asthma	1.11e-05	8.91e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR4—asthma	1.11e-05	8.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DRB1—asthma	1.11e-05	8.89e-05	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—asthma	1.11e-05	8.88e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—SERPINE1—asthma	1.11e-05	8.87e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PPP2CA—asthma	1.11e-05	8.86e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—BCL2—asthma	1.1e-05	8.83e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LTC4S—asthma	1.1e-05	8.82e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NQO1—asthma	1.1e-05	8.79e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALOX5—asthma	1.1e-05	8.79e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—asthma	1.1e-05	8.77e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.1e-05	8.77e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PDGFB—asthma	1.1e-05	8.77e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6R—asthma	1.09e-05	8.75e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IFNG—asthma	1.09e-05	8.75e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR5—asthma	1.09e-05	8.7e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ADCY2—asthma	1.07e-05	8.6e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2RA—asthma	1.07e-05	8.57e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—KNG1—asthma	1.07e-05	8.57e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—asthma	1.07e-05	8.55e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—RHOA—asthma	1.07e-05	8.55e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ICAM1—asthma	1.07e-05	8.53e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AGTR1—asthma	1.06e-05	8.52e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—PTEN—asthma	1.06e-05	8.5e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—C3—asthma	1.06e-05	8.5e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—asthma	1.06e-05	8.46e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD4—asthma	1.06e-05	8.45e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	1.05e-05	8.42e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CARM1—asthma	1.05e-05	8.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL10—asthma	1.04e-05	8.32e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PDGFB—asthma	1.03e-05	8.27e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—DCN—asthma	1.03e-05	8.26e-05	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—asthma	1.03e-05	8.22e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SERPINE1—asthma	1.02e-05	8.19e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NTRK1—asthma	1.02e-05	8.16e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—asthma	1.01e-05	8.1e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADRB2—asthma	1.01e-05	8.08e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.01e-05	8.05e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALDH2—asthma	1e-05	8.04e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GSTP1—asthma	9.98e-06	7.99e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—STAT3—asthma	9.95e-06	7.97e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LEP—asthma	9.89e-06	7.91e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—RHOA—asthma	9.87e-06	7.9e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	9.87e-06	7.9e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—HMOX1—asthma	9.84e-06	7.88e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ITPR1—asthma	9.82e-06	7.86e-05	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—asthma	9.8e-06	7.84e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—asthma	9.77e-06	7.82e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS2—asthma	9.76e-06	7.81e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—asthma	9.75e-06	7.8e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD4—asthma	9.74e-06	7.8e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALOX15—asthma	9.74e-06	7.8e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALOX5AP—asthma	9.74e-06	7.8e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL2—asthma	9.71e-06	7.77e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CAT—asthma	9.71e-06	7.77e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—asthma	9.67e-06	7.74e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—VEGFA—asthma	9.6e-06	7.68e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LTA4H—asthma	9.56e-06	7.65e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTT1—asthma	9.55e-06	7.64e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ITPR1—asthma	9.55e-06	7.64e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6R—asthma	9.51e-06	7.61e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—STAT3—asthma	9.5e-06	7.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—EGFR—asthma	9.46e-06	7.57e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	9.39e-06	7.52e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—FN1—asthma	9.32e-06	7.46e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CHAT—asthma	9.29e-06	7.44e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—asthma	9.23e-06	7.38e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GSTM1—asthma	9.17e-06	7.34e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PLA2G4A—asthma	9.17e-06	7.34e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GSTP1—asthma	9.16e-06	7.33e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—PTEN—asthma	9.14e-06	7.31e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CD86—asthma	9.09e-06	7.28e-05	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—EGFR—asthma	9.09e-06	7.27e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—EGFR—asthma	9.05e-06	7.24e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—HMOX1—asthma	9.03e-06	7.23e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—EDN1—asthma	9.02e-06	7.22e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ITPR1—asthma	9.01e-06	7.21e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL5—asthma	8.95e-06	7.16e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PLA2G4A—asthma	8.92e-06	7.14e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CAT—asthma	8.91e-06	7.13e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CSF2—asthma	8.82e-06	7.06e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—asthma	8.81e-06	7.05e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6R—asthma	8.78e-06	7.03e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—asthma	8.67e-06	6.94e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—EGFR—asthma	8.64e-06	6.91e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SMAD3—asthma	8.58e-06	6.87e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—POMC—asthma	8.49e-06	6.8e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPP2CA—asthma	8.45e-06	6.76e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTEN—asthma	8.44e-06	6.75e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PLA2G4A—asthma	8.42e-06	6.74e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GSTM1—asthma	8.42e-06	6.74e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ARG1—asthma	8.36e-06	6.69e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—asthma	8.31e-06	6.65e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALOX5—asthma	8.28e-06	6.63e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6R—asthma	8.28e-06	6.63e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2—asthma	8.28e-06	6.63e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—SERPINE1—asthma	8.22e-06	6.58e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PPP2CA—asthma	8.21e-06	6.57e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—BCL2—asthma	8.18e-06	6.55e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—STAT3—asthma	8.17e-06	6.54e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNG—asthma	8.11e-06	6.49e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR5—asthma	8.06e-06	6.45e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2RA—asthma	7.95e-06	6.36e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NQO1—asthma	7.94e-06	6.35e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—RHOA—asthma	7.93e-06	6.35e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CARM1—asthma	7.9e-06	6.32e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—C3—asthma	7.88e-06	6.31e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—asthma	7.85e-06	6.28e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—asthma	7.84e-06	6.27e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD4—asthma	7.83e-06	6.27e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—PTEN—asthma	7.79e-06	6.24e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—DCN—asthma	7.79e-06	6.23e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ADCY2—asthma	7.77e-06	6.22e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SERPINE1—asthma	7.76e-06	6.21e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPP2CA—asthma	7.75e-06	6.2e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PDGFB—asthma	7.67e-06	6.14e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALDH2—asthma	7.58e-06	6.06e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALDH7A1—asthma	7.56e-06	6.05e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—STAT3—asthma	7.54e-06	6.04e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RHOA—asthma	7.48e-06	5.99e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—EGFR—asthma	7.43e-06	5.94e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—asthma	7.41e-06	5.93e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LEP—asthma	7.34e-06	5.87e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—asthma	7.27e-06	5.82e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ARG2—asthma	7.24e-06	5.8e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—asthma	7.23e-06	5.79e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD4—asthma	7.23e-06	5.79e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTT1—asthma	7.21e-06	5.77e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2—asthma	7.21e-06	5.77e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—asthma	7.18e-06	5.74e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VEGFA—asthma	7.04e-06	5.63e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—asthma	6.99e-06	5.6e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—STAT3—asthma	6.97e-06	5.58e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—asthma	6.95e-06	5.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—FN1—asthma	6.92e-06	5.54e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—EGFR—asthma	6.86e-06	5.49e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PTEN—asthma	6.78e-06	5.43e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—asthma	6.64e-06	5.31e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTP1—asthma	6.62e-06	5.3e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—asthma	6.57e-06	5.26e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HMOX1—asthma	6.53e-06	5.23e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ITPR1—asthma	6.51e-06	5.21e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—POMC—asthma	6.48e-06	5.19e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—asthma	6.46e-06	5.17e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CAT—asthma	6.44e-06	5.16e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—EGFR—asthma	6.34e-06	5.07e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ALB—asthma	6.32e-06	5.05e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—POMC—asthma	6.3e-06	5.04e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2—asthma	6.28e-06	5.02e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTEN—asthma	6.26e-06	5.01e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—asthma	6.17e-06	4.93e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6R—asthma	6.15e-06	4.92e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PLA2G4A—asthma	6.08e-06	4.87e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTM1—asthma	6.08e-06	4.87e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—STAT3—asthma	6.06e-06	4.85e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALOX15—asthma	6e-06	4.8e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALOX5AP—asthma	6e-06	4.8e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NQO1—asthma	5.99e-06	4.79e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—POMC—asthma	5.95e-06	4.76e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—asthma	5.94e-06	4.76e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALB—asthma	5.91e-06	4.73e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PTEN—asthma	5.91e-06	4.73e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ADCY2—asthma	5.86e-06	4.69e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SERPINE1—asthma	5.76e-06	4.61e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CHAT—asthma	5.73e-06	4.58e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—asthma	5.71e-06	4.57e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—asthma	5.65e-06	4.52e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPP2CA—asthma	5.6e-06	4.48e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—STAT3—asthma	5.6e-06	4.48e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RHOA—asthma	5.55e-06	4.44e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—EGFR—asthma	5.51e-06	4.41e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—asthma	5.5e-06	4.4e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALB—asthma	5.42e-06	4.34e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VEGFA—asthma	5.34e-06	4.27e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—STAT3—asthma	5.28e-06	4.23e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—asthma	5.27e-06	4.22e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—asthma	5.19e-06	4.15e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—asthma	5.19e-06	4.15e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—asthma	5.17e-06	4.14e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALOX5—asthma	5.1e-06	4.08e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—EGFR—asthma	5.09e-06	4.07e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTP1—asthma	5e-06	4e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HMOX1—asthma	4.93e-06	3.94e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ITPR1—asthma	4.92e-06	3.93e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—asthma	4.9e-06	3.92e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—asthma	4.88e-06	3.9e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—asthma	4.87e-06	3.9e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CARM1—asthma	4.87e-06	3.9e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CAT—asthma	4.86e-06	3.89e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—EGFR—asthma	4.8e-06	3.84e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—DCN—asthma	4.8e-06	3.84e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—asthma	4.74e-06	3.8e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALDH2—asthma	4.67e-06	3.74e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2—asthma	4.66e-06	3.73e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTM1—asthma	4.59e-06	3.67e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PLA2G4A—asthma	4.59e-06	3.67e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTEN—asthma	4.51e-06	3.61e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTT1—asthma	4.44e-06	3.55e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—asthma	4.41e-06	3.53e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PTEN—asthma	4.38e-06	3.51e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—POMC—asthma	4.3e-06	3.44e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—asthma	4.24e-06	3.39e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPP2CA—asthma	4.23e-06	3.38e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTEN—asthma	4.14e-06	3.31e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VEGFA—asthma	3.96e-06	3.17e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—STAT3—asthma	3.92e-06	3.14e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALB—asthma	3.92e-06	3.14e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—asthma	3.91e-06	3.13e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—asthma	3.75e-06	3e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—asthma	3.69e-06	2.95e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NQO1—asthma	3.69e-06	2.95e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—asthma	3.63e-06	2.91e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ADCY2—asthma	3.61e-06	2.89e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—EGFR—asthma	3.56e-06	2.85e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—asthma	3.43e-06	2.74e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—POMC—asthma	3.24e-06	2.6e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTP1—asthma	3.08e-06	2.46e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HMOX1—asthma	3.04e-06	2.43e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ITPR1—asthma	3.03e-06	2.42e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CAT—asthma	2.99e-06	2.4e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTEN—asthma	2.99e-06	2.39e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALB—asthma	2.96e-06	2.37e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—asthma	2.83e-06	2.26e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLA2G4A—asthma	2.83e-06	2.26e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTM1—asthma	2.83e-06	2.26e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—asthma	2.74e-06	2.19e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPP2CA—asthma	2.6e-06	2.08e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—asthma	2.59e-06	2.07e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTEN—asthma	2.26e-06	1.81e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—POMC—asthma	2e-06	1.6e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALB—asthma	1.82e-06	1.46e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—asthma	1.74e-06	1.4e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—asthma	1.59e-06	1.28e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTEN—asthma	1.39e-06	1.11e-05	CbGpPWpGaD
